|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM035728604 |
| 003 |
DE-627 |
| 005 |
20250126210424.0 |
| 007 |
tu |
| 008 |
231221s1987 xx ||||| 00| ||jpn c |
| 028 |
5 |
2 |
|a pubmed25n0119.xml
|
| 035 |
|
|
|a (DE-627)NLM035728604
|
| 035 |
|
|
|a (NLM)3591595
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Yoneyama, T
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Clinical effect of terodiline hydrochloride on nervous pollakisuria or irritative bladder
|
| 264 |
|
1 |
|c 1987
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 14.07.1987
|
| 500 |
|
|
|a Date Revised 15.11.2012
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a The clinical effect of terodiline hydrochloride (TD-758) was studied in 95 patients with nervous pollakisuria or irritative bladder. TD-758 was given per os randomly at a dose of 24 mg or 12 mg once a day for 4 weeks. The symptoms such as urinary frequency, urinary incontinence and sense of residual urine were improved in 74% of the patients taking 24 mg, and in 51% of the patients taking 12 mg. The difference was statistically significant. Side effects such as dry mouth, constipation and heart burn were observed in 15% of the patients in each group and were not serious. The results of this study indicate that TD-758 is useful for these patients and its optimal dosage is 24 mg once a day
|
| 650 |
|
4 |
|a Clinical Trial
|
| 650 |
|
4 |
|a English Abstract
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Randomized Controlled Trial
|
| 650 |
|
7 |
|a Butylamines
|2 NLM
|
| 650 |
|
7 |
|a Calcium Channel Blockers
|2 NLM
|
| 650 |
|
7 |
|a terodiline
|2 NLM
|
| 650 |
|
7 |
|a 70KG06964W
|2 NLM
|
| 700 |
1 |
|
|a Ogawa, A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Fukui, J
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wajiki, M
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tomita, Y
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Igawa, Y
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yanagisawa, A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Uchiyama, S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Watanabe, K
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Aida, Y
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 33(1987), 2 vom: 01. Feb., Seite 319-26
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
| 773 |
1 |
8 |
|g volume:33
|g year:1987
|g number:2
|g day:01
|g month:02
|g pages:319-26
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 33
|j 1987
|e 2
|b 01
|c 02
|h 319-26
|